Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) is a relatively rare

The U.S. Food and Drug Administration today has approved Imbruvica (ibrutinib) for the

The Leukemia and Lymphoma Society, the largest charity in the world dedicated to blood

Changing R-CHOP improved outcomes in patients with mantle cell lymphoma (MCL), according

A new study in the New England Journal of Medicine points towards a more tolerable

Because science has only recently became familiar with mantle cell lymphoma, there aer not

Mantle cell lymphoma (MCL), a rare disease that has been difficult to study in clinical

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It

Mantle cell lymphoma (MCL) is a very rare and difficult to

On June 5, the U.S. Food and Drug Administration notified Celgene corporation that the

Among the many fairly commonly mentioned subtypes of non-Hodgkin

According to new data presented at the meeting of the American Association for Cancer

Results of a recently published Phase II study by Italian researchers indicate that